Published in Chem Biol on July 01, 2007
Myristoylation and membrane binding regulate c-Src stability and kinase activity. Mol Cell Biol (2010) 1.33
Protein N-terminal processing: substrate specificity of Escherichia coli and human methionine aminopeptidases. Biochemistry (2010) 1.08
A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products. J Nat Prod (2009) 0.98
Myxobacteria versus sponge-derived alkaloids: the bengamide family identified as potent immune modulating agents by scrutiny of LC-MS/ELSD libraries. Bioorg Med Chem (2012) 0.87
Inhibition of Mycobacterium tuberculosis methionine aminopeptidases by bengamide derivatives. ChemMedChem (2011) 0.86
Substituted oxines inhibit endothelial cell proliferation and angiogenesis. Org Biomol Chem (2012) 0.81
NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells. Mol Cancer (2009) 0.81
Cellular FRET-Biosensors to Detect Membrane Targeting Inhibitors of N-Myristoylated Proteins. PLoS One (2013) 0.79
Methionine aminopeptidase 2 is required for HSC initiation and proliferation. Blood (2011) 0.78
Chemistry and biology of bengamides and bengazoles, bioactive natural products from Jaspis sponges. Mar Drugs (2014) 0.77
Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells. J Med Chem (2013) 0.77
Team work in protein processing. Chem Biol (2007) 0.75
The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects. J Nat Prod (2017) 0.75
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell (1991) 15.76
The N-end rule: functions, mysteries, uses. Proc Natl Acad Sci U S A (1996) 6.51
The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci U S A (1997) 3.23
Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A. J Biol Chem (2006) 2.67
Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. Proc Natl Acad Sci U S A (1995) 2.57
Methionine aminopeptidase gene of Escherichia coli is essential for cell growth. J Bacteriol (1989) 2.52
Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem Biol (1997) 2.38
Genome-wide functional analysis of human cell-cycle regulators. Proc Natl Acad Sci U S A (2006) 2.31
Altered phosphorylation and activation of pp60c-src during fibroblast mitosis. Cell (1988) 2.30
Myristoylation. Cell Signal (1997) 2.27
Inhibition of eukaryotic translation initiation by the marine natural product pateamine A. Mol Cell (2005) 2.17
Selected glimpses into the activation and function of Src kinase. Oncogene (2000) 2.16
Structure and function of the methionine aminopeptidases. Biochim Biophys Acta (2000) 2.09
Chemical rescue of a mutant enzyme in living cells. Science (2006) 1.95
A chemical and genetic approach to the mode of action of fumagillin. Chem Biol (2006) 1.91
Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division. Science (1995) 1.85
Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol (1995) 1.77
The mechanism of glutamine-dependent amidotransferases. Cell Mol Life Sci (1998) 1.44
Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. Proc Natl Acad Sci U S A (2000) 1.39
Methionine in and out of proteins: targets for drug design. Curr Med Chem (2002) 1.38
Fyn/Yes and non-canonical Wnt signalling converge on RhoA in vertebrate gastrulation cell movements. EMBO Rep (2005) 1.38
Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell (2005) 1.37
The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest. Proc Natl Acad Sci U S A (2000) 1.33
Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Chem Biol (1999) 1.32
Catabolism of intracellular N-terminal acetylated proteins: involvement of acylpeptide hydrolase and acylase. Biochimie (2005) 1.23
Protein tyrosine kinases Src and Csk: a tail's tale. Curr Opin Chem Biol (2003) 1.21
Structural basis for the functional differences between type I and type II human methionine aminopeptidases. Biochemistry (2005) 1.20
Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. J Med Chem (2003) 1.17
Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression. Proc Natl Acad Sci U S A (2006) 1.14
Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors. J Biol Chem (2003) 1.13
Bengamides revisited: new structures and antitumor studies. J Org Chem (2001) 1.10
Suppression of hepatoma growth and angiogenesis by a fumagillin derivative TNP470: possible involvement of nitric oxide synthase. Cancer Res (1998) 0.97
The specificity in vivo of two distinct methionine aminopeptidases in Saccharomyces cerevisiae. Arch Biochem Biophys (2002) 0.96
Identification of pyridinylpyrimidines as inhibitors of human methionine aminopeptidases. Angew Chem Int Ed Engl (2006) 0.95
Synthesis and antitumor activity of ester-modified analogues of bengamide B. J Med Chem (2001) 0.94
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2. Cancer Res (2003) 0.93
Distribution of ARF6 between membrane and cytosol is regulated by its GTPase cycle. J Biol Chem (1999) 0.93
A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancer. Anticancer Drugs (2007) 0.92
Isolation of the murine S100 protein MRP14 (14 kDa migration-inhibitory-factor-related protein) from activated spleen cells: characterization of post-translational modifications and zinc binding. Biochem J (1996) 0.92
Drosophila ACT88F indirect flight muscle-specific actin is not N-terminally acetylated: a mutation in N-terminal processing affects actin function. J Mol Biol (2000) 0.87
Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo. J Med Chem (2006) 0.85
Recombinant bovine rhodanese: purification and comparison with bovine liver rhodanese. Biochim Biophys Acta (1992) 0.82
TNP-470 inhibits oxidative stress, nitric oxide production and nuclear factor kappa B activation in a rat model of hepatocellular carcinoma. Free Radic Res (2003) 0.81
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell (2004) 21.30
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell (2006) 10.28
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell (2004) 4.98
Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci U S A (2008) 4.79
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev (2012) 4.19
Regulation of the p300 HAT domain via a novel activation loop. Nat Struct Mol Biol (2004) 3.70
Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells (2010) 3.53
Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat Chem Biol (2010) 3.44
A Src-like inactive conformation in the abl tyrosine kinase domain. PLoS Biol (2006) 3.40
Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol (2010) 3.38
The HBV drug entecavir - effects on HIV-1 replication and resistance. N Engl J Med (2007) 3.20
Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron (2010) 3.15
The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature (2008) 2.83
Mechanism of activation and inhibition of the HER4/ErbB4 kinase. Structure (2008) 2.79
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature (2007) 2.78
A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov (2011) 2.77
Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science (2009) 2.76
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest (2009) 2.75
A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol (2006) 2.72
Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A. J Biol Chem (2006) 2.67
Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell (2010) 2.54
Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir. J Natl Cancer Inst (2012) 2.47
Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science (2009) 2.39
Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc Natl Acad Sci U S A (2009) 2.33
Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc Natl Acad Sci U S A (2006) 2.30
DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol Cell (2002) 2.29
RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol Cell Biol (2007) 2.20
Inhibition of eukaryotic translation initiation by the marine natural product pateamine A. Mol Cell (2005) 2.17
Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science (2010) 2.12
Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J Biol Chem (2003) 2.06
Inhibition of angiogenesis by the antifungal drug itraconazole. ACS Chem Biol (2007) 2.00
Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. Proc Natl Acad Sci U S A (2009) 1.95
Chemical rescue of a mutant enzyme in living cells. Science (2006) 1.95
Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res (2003) 1.91
XPB, a subunit of TFIIH, is a target of the natural product triptolide. Nat Chem Biol (2011) 1.89
Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat Struct Mol Biol (2008) 1.89
The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation. J Biol Chem (2008) 1.83
Polyketide assembly lines of uncultivated sponge symbionts from structure-based gene targeting. Nat Chem Biol (2009) 1.75
Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc Natl Acad Sci U S A (2002) 1.72
Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function. Curr Opin Struct Biol (2008) 1.72
Psymberin, a potent sponge-derived cytotoxin from Psammocinia distantly related to the pederin family. Org Lett (2004) 1.72
Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. Science (2011) 1.70
Structural basis for the recognition of c-Src by its inactivator Csk. Cell (2008) 1.66
A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. EMBO J (2003) 1.65
Construction of human activity-based phosphorylation networks. Mol Syst Biol (2013) 1.59
The chemical biology of protein phosphorylation. Annu Rev Biochem (2009) 1.59
Structural basis of histone demethylation by LSD1 revealed by suicide inactivation. Nat Struct Mol Biol (2007) 1.59
Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains. EMBO J (2010) 1.58
Reading dynamic kinase activity in living cells for high-throughput screening. ACS Chem Biol (2006) 1.54
Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc Natl Acad Sci U S A (2010) 1.53
Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res (2002) 1.53
Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol Cell Biol (2005) 1.52
LSD1 and the chemistry of histone demethylation. Curr Opin Chem Biol (2007) 1.52
Reading and function of a histone code involved in targeting corepressor complexes for repression. Mol Cell Biol (2005) 1.52
The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science (2011) 1.49
Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Biochemistry (2007) 1.44
A mechanism-based inactivator for histone demethylase LSD1. J Am Chem Soc (2006) 1.43
Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol Cell (2003) 1.42
Molecular cloning and characterization of rat LC3A and LC3B--two novel markers of autophagosome. Biochem Biophys Res Commun (2005) 1.41
Acetylation of RNA polymerase II regulates growth-factor-induced gene transcription in mammalian cells. Mol Cell (2013) 1.40
Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines. Mol Cancer Ther (2011) 1.39
TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. Proc Natl Acad Sci U S A (2007) 1.39
HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. Proc Natl Acad Sci U S A (2008) 1.39
Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. J Mol Biol (2005) 1.38
Calcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization. J Biol Chem (2007) 1.38
Electrophilic tuning of the chemoprotective natural product sulforaphane. Proc Natl Acad Sci U S A (2010) 1.37
The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation. J Biol Chem (2002) 1.34
Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology (2013) 1.34
Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2. Nature (2003) 1.32
Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target. J Med Chem (2006) 1.31
Csk, a critical link of g protein signals to actin cytoskeletal reorganization. Dev Cell (2002) 1.30
Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP. Proc Natl Acad Sci U S A (2011) 1.30
Simultaneous arming and structure/activity studies of natural products employing O-H insertions: an expedient and versatile strategy for natural products-based chemical genetics. J Am Chem Soc (2007) 1.29
Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. J Am Chem Soc (2010) 1.29
Asperazine, a Selective Cytotoxic Alkaloid from a Sponge-Derived Culture of Aspergillus niger. J Org Chem (1997) 1.27
A new paradigm for the development of anticancer agents from natural products. J Exp Ther Oncol (2006) 1.27
Kinetic and mass spectrometric analysis of p300 histone acetyltransferase domain autoacetylation. J Biol Chem (2006) 1.26
Sponge-derived fijianolide polyketide class: further evaluation of their structural and cytotoxicity properties. J Med Chem (2007) 1.26
Probing the bioactive constituents from chemotypes of the sponge Psammocinia aff. bulbosa. J Nat Prod (2007) 1.26
Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth. Prostate (2010) 1.25
Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferase. J Org Chem (2003) 1.25
p300/CBP-associated factor drives DEK into interchromatin granule clusters. J Biol Chem (2005) 1.24
Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis. Nat Chem Biol (2012) 1.24
MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. FASEB J (2012) 1.24
Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells. J Med Chem (2009) 1.23
Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity. Proc Natl Acad Sci U S A (2006) 1.23
NMR strategy for unraveling structures of bioactive sponge-derived oxy-polyhalogenated diphenyl ethers. J Nat Prod (2009) 1.23
Effect of nitroxoline on angiogenesis and growth of human bladder cancer. J Natl Cancer Inst (2010) 1.22
A new structural theme in the imidazole-containing alkaloids from a calcareous Leucetta sponge. J Org Chem (2004) 1.22